The cooperation of Koçyiğit with his co-workers proved that a chalcone derivative incorporating Schiff base C acts as an acetylcholinesterase (AChE) inhibitor for treating Alzheimer’s disease [16]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.